Cancer treatments' provider AstraZeneca PLC ( AZN ) posted a nice set of Q3 2025 and 9M 2025 results earlier today. With healthy increases seen even until H1 2025 and given the outlook for 2025 so far, this was to be expected.Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green G ...